Test-tube kids and cancer? Method unlikely a cause

July 19, 2010 By LINDSEY TANNER , AP Medical Writer

(AP) -- For the first time, a large study suggests a higher rate of childhood cancer among test-tube babies, but researchers say the reason probably has nothing to do with how the infants were conceived.

More likely, it's related to the genetics of the parents who turned to because of , the study's Swedish authors and other experts say. Also, test-tube infants often are born prematurely and have breathing problems at birth - traits linked in other studies with increased risks.

Still, cancer in these children is rare despite any elevated risks.

"It's rather reassuring," said Dr. Bengt Kallen, the study's lead author and a researcher at the University of Lund. The risk "is so small that it can't matter much for the individual parents or parents-to-be."

The study examined Swedish children conceived by , in which eggs are fertilized with sperm in a lab dish and then implanted in the . Research on possible health risks including cancer and birth defects in IVF children has had mixed results.

Dr. Tommaso Falcone, the Cleveland Clinic's obstetrics and gynecology chief, said it's uncertain whether similar results would be found in the more racially diverse United States. About 57,000 infants are born after IVF each year in the U.S., or roughly 1 percent of all births

The results of the new study were published online Monday in Pediatrics. It analyzed more than 2.4 million births in Sweden between 1982 and 2005, including almost 27,000 IVF babies, along with cancer data in children tracked for up to 19 years.

Overall, 53 IVF children developed cancer versus 38 that would be expected in other children of the same age, a 42 percent increased risk. Leukemia and brain cancers were among the most common.

Kallen said possible reasons for the link include unidentified traits in the parents that might be related to infertility and cancer risks.

Absolute risks for cancer in these children are still very low, "far less than 1 percent," Falcone noted.

Dr. Elizabeth Ginsburg, medical director of the IVF program at Harvard's Brigham and Women's Hospital, said patients nonetheless should be counseled about the study results.

More information: Pediatrics: http://www.pediatrics.org
IVF information: http://bit.ly/aBFyva

shares

Related Stories

Recommended for you

Tracking how multiple myeloma evolves by sequencing DNA in the blood

December 10, 2017
Although people with multiple myeloma usually respond well to treatment, the blood cancer generally keeps coming back. Following genetic changes in how the disease evolves over time will help to understand the disease and, ...

Landmark CAR-T cancer study published

December 10, 2017
Loyola University Medical Center is the only Chicago center that participated in the pivotal clinical trial of a groundbreaking cancer treatment that genetically engineers a patient's immune system to attack cancer cells.

Study finds emojis promising tool for tracking cancer patients' quality of life

December 10, 2017
In findings presented to the American Society of Hematology, Mayo Clinic researchers found that using emojis instead of traditional emotional scales were helpful in assessing patients' physical, emotional and overall quality ...

Study explores use of checkpoint inhibitors after relapse from donor stem cell transplant

December 10, 2017
Immunotherapy agents known as checkpoint inhibitors have shown considerable promise in patients with hematologic cancers who relapse after a transplant with donor stem cells. Preliminary results from the first clinical trial ...

Blood test may help predict which breast cancers will recur

December 8, 2017
A blood test five years after breast cancer treatment helped identify some women who were more likely to relapse, long before a lump or other signs appeared, a preliminary study found.

Alcohol-abuse drug Antabuse kills cancer cells

December 8, 2017
A new study in Nature by an international team including researchers from Karolinska Institutet, reports that the alcohol-abuse drug Antabuse is effective against cancer. The study also identifies a potential mechanism of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.